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WHO position
The main aim of pertussis vaccination is to reduce the risk of severe pertussis in infants and young children, due to the high morbidity and mortality caused by the disease in this age group.
All children worldwide, including HIV-positive individuals, should be immunized against pertussis. Every country should seek to achieve early and timely vaccination initiated not later than 8 weeks of age, and maintain high coverage (≥90%) with at least 3 doses of assured quality pertussis vaccine at all levels (national and subnational). This will ensure high levels of protection in children in the < 5 year age group.
The duration of protection following primary immunization varies considerably depending upon factors such as local epidemiology, vaccination schedule and choice of vaccine. Therefore, a booster dose is recommended for children aged 1-6 years, preferably during the second year of life (≥6 months after last primary dose) .
Only aP-containing vaccines should be used for vaccination of persons aged ≥7 years. 
